nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.07.2019 | Original Article

Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?

verfasst von: A. B. Moraes, E. M. R. Cavalari, M. P. de Paula, M. Arruda, D. S. C. Curi, R. A. Leitão, L. M. C. de Mendonça, M. L. F. Farias, M. Madeira, L. Vieira Neto

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Metabolic syndrome (MS) and sarcopenia are associated with increased cardiovascular risk. No studies using dual-energy x-ray absorptiometry (DXA) have evaluated association between body composition (BC) changes and MS in adrenal incidentaloma (AI). Our aim was to analyse BC in non-functioning AI (NFAI) and intermediate phenotype (IP) relative to controls and to correlate with cortisol levels.

Methods

Cross-sectional study with 44 NFAI (serum cortisol ≤ 50 nmol/L after the overnight 1 mg dexamethasone suppression test), 27 IP (cortisol 51–138 nmol/L), and 41 controls (normal adrenal on imaging examination) using DXA. Autonomic cortisol secretion (cortisol > 138 nmol/L) was excluded from the study. BC data were compared using criteria for MS (World Health Organization, National Cholesterol Education Program-Adult Treatment Panel-III, American Association of Clinical Endocrinologists (AACE), and International Diabetes Federation).

Results

There was no significant difference in clinical data and body mass index (BMI) among the three groups. Waist circumference (WC) was larger in AI vs. controls (p < 0.01). Waist-to-hip ratio was higher in NFAI vs. controls and waist-to-height ratio was higher in IP vs. controls (p = 0.03 and p = 0.02, respectively). The frequency of MS was higher in AI vs. controls. BC was not different among the groups. Patients with AI there was a significant association of MS with both an increase in total fat and body fat index (all criteria), and a significant difference between MS and smaller BMI-adjusted lean mass (AACE, p = 0.036). No correlation of cortisol after 1 mg dexamethasone test with BC or MS. AI and WC were independently associated with MS.

Conclusions

AI presented high frequency of MS and was independently associated with MS. Possible deleterious effects of cortisol secretion seem to initially affect the muscular system.

Aron D, Terzolo M, Cawood TJ (2012) Adrenal incidentalomas. Best Pract Res Clin Endocrinol 26(1):69–82. https://doi.org/10.1016/j.beem.2011.06.012 CrossRef

Debono M, Newell-Price J (2015) Subclinical hypercortisolism in adrenal incidentaloma. Curr Opin Endocrinol Diabetes Obes 22(3):185–192. https://doi.org/10.1097/MED.0000000000000151 CrossRefPubMed

Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85(2):637–644. https://doi.org/10.1210/jcem.85.2.6372 CrossRefPubMed

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol Eur Fed Endocr Soc 175(2):G1–G34. https://doi.org/10.1530/EJE-16-0467 CrossRef

Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G (2002) Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocr Metab 87(11):4872–4878. https://doi.org/10.1210/jc.2001-011766 CrossRefPubMed

Di Dalmazi G, Fanelli F, Mezzullo M, Casadio E, Rinaldi E, Garelli S, Giampalma E, Mosconi C, Golfieri R, Vicennati V, Pagotto U, Pasquali R (2015) Steroid profiling by LC-MS/MS in nonsecreting and subclinical cortisol-secreting adrenocortical adenomas. J Clin Endocrinol Metab 100(9):3529–3538. https://doi.org/10.1210/JC.2015-1992 CrossRefPubMed

Di Dalmazi G, Vicennati V, Rinaldi E, Morselli-Labate AM, Giampalma E, Mosconi C, Pagotto U, Pasquali R (2012) Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol Eur Fed Endocr Soc 166(4):669–677. https://doi.org/10.1530/EJE-11-1039 CrossRef

Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M, Ambrosi B, Scillitani A, Ghigo E, Beck-Peccoz P, Terzolo M, Chiodini I (2014) Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab 99(3):827–834. https://doi.org/10.1210/jc.2013-3527 CrossRefPubMed

Masserini B, Morelli V, Palmieri S, Eller-Vainicher C, Zhukouskaya V, Cairoli E, Orsi E, Beck-Peccoz P, Spada A, Chiodini I (2015) Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism. J Endocrinol Investig 38(6):623–628. https://doi.org/10.1007/s40618-014-0232-0 CrossRef

10.

Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med J Br Diabetic Assoc 15(7):539–553. https://doi.org/10.1002/(sici)1096-9136(199807)15:7%3c539:aid-dia668%3e3.0.co;2-s CrossRef

11.

Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA J Am Med Assoc 285(19):2486–2497CrossRef

12.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Fernando C (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol 4(4):198–203CrossRefPubMed

13.

Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9(3):237–252PubMed

14.

Alberti KG, Zimmet P, Shaw J, Group IDFETFC (2005) The metabolic syndrome—a new worldwide definition. Lancet 366(9491):1059–1062. https://doi.org/10.1016/S0140-6736(05)67402-8 CrossRef

15.

Shin D, Kongpakpaisarn K, Bohra C (2018) Trends in the prevalence of metabolic syndrome and its components in the United States 2007–2014. Int J Cardiol 259:216–219. https://doi.org/10.1016/j.ijcard.2018.01.139 CrossRefPubMed

16.

Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One 4(9):e7038. https://doi.org/10.1371/journal.pone.0007038 CrossRefPubMedPubMedCentral

17.

Fan B, Shepherd JA, Levine MA, Steinberg D, Wacker W, Barden HS, Ergun D, Wu XP (2014) National health and nutrition examination survey whole-body dual-energy X-ray absorptiometry reference data for GE lunar systems. J Clin Densitom 17(3):344–377. https://doi.org/10.1016/j.jocd.2013.08.019 CrossRefPubMed

18.

Sasai H, Brychta RJ, Wood RP, Rothney MP, Zhao X, Skarulis MC, Chen KY (2015) Does visceral fat estimated by dual-energy X-ray absorptiometry independently predict cardiometabolic risks in adults? J Diabetes Sci Technol 9(4):917–924. https://doi.org/10.1177/1932296815577424 CrossRefPubMedPubMedCentral

19.

Edwards MH, Buehring B (2015) Novel approaches to the diagnosis of sarcopenia. J Clin Densitom 18(4):472–477. https://doi.org/10.1016/j.jocd.2015.04.010 CrossRefPubMed

20.

Cooper R, Kuh D, Hardy R, Mortality Review G, Falcon Teams HAS (2010) Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 341:c4467. https://doi.org/10.1136/bmj.c4467 CrossRefPubMedPubMedCentral

21.

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee (1995). World Health Organization technical report series 854:1–452

22.

Nishida C, Ko GT, Kumanyika S (2010) Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO expert consultation on waist circumference and waist-hip ratio. Eur J Clin Nutr 64(1):2–5. https://doi.org/10.1038/ejcn.2009.139 CrossRefPubMed

23.

Browning LM, Hsieh SD, Ashwell M (2010) A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Revi 23(2):247–269. https://doi.org/10.1017/s0954422410000144 CrossRef

24.

Arruda M, Mello Ribeiro Cavalari E, Pessoa de Paula M, Cordeiro Fernandes, de Morais F, Furtado Bilro G, Alves Coelho MC, Choeri D, Moraes A, Vieira Neto L (2018) The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J Hum Hypertens 32(1):3–11. https://doi.org/10.1038/s41371-017-0011-4 CrossRef

25.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA J Am Med Assoc 311(5):507–520. https://doi.org/10.1001/jama.2013.284427 CrossRef

26.

Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, Endocrine S (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915–1942. https://doi.org/10.1210/jc.2014-1498 CrossRefPubMed

27.

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young Jr WF (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2015-4061 CrossRefPubMed

28.

Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP, Sieber C, Stout JR, Studenski SA, Vellas B, Woo J, Zamboni M, Cederholm T (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759. https://doi.org/10.1093/ageing/afu115 CrossRefPubMedPubMedCentral

29.

Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763CrossRefPubMed

30.

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biol Sci Med Sci 69(5):547–558. https://doi.org/10.1093/gerona/glu010 CrossRef

31.

Ribeiro Cavalari EM, de Paula MP, Arruda M, Carraro N, Martins A, de Souza K, Coelho MC, de Oliveira ESdMNA, Moraes AB, Vieira Neto L (2018) Nonfunctioning adrenal incidentaloma: a novel predictive factor for metabolic syndrome. Clin Endocrinol. https://doi.org/10.1111/cen.13822 CrossRef

32.

Donini LM, Poggiogalle E, Del Balzo V, Lubrano C, Faliva M, Opizzi A, Perna S, Pinto A, Rondanelli M (2013) How to estimate fat mass in overweight and obese subjects. Int J Endocrinol 2013:285680. https://doi.org/10.1155/2013/285680 CrossRefPubMedPubMedCentral

33.

Deurenberg P (1996) Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity. Am J Clin Nutr 64(3 Suppl):449S–452SCrossRefPubMed

34.

Johnson Stoklossa CA, Forhan M, Padwal RS, Gonzalez MC, Prado CM (2016) Practical considerations for body composition assessment of adults with class II/III obesity using bioelectrical impedance analysis or dual-energy X-ray absorptiometry. Curr Obes Rep 5(4):389–396. https://doi.org/10.1007/s13679-016-0228-5 CrossRefPubMed

35.

Kamel EG, McNeill G, Han TS, Smith FW, Avenell A, Davidson L, Tothill P (1999) Measurement of abdominal fat by magnetic resonance imaging, dual-energy X-ray absorptiometry and anthropometry in non-obese men and women. Int J Obes Relat Metab Disord J Int Assoc Study Obes 23(7):686–692CrossRef

36.

Jensen MD, Kanaley JA, Reed JE, Sheedy PF (1995) Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr 61(2):274–278. https://doi.org/10.1093/ajcn/61.2.274 CrossRefPubMed

37.

Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, Ergun DL (2012) Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity 20(6):1313–1318. https://doi.org/10.1038/oby.2011.393 CrossRefPubMed

38.

Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E (2001) Body composition and metabolic features in women with adrenal incidentaloma or Cushing’s syndrome. J Clin Endocrinol Metab 86(11):5301–5306. https://doi.org/10.1210/jcem.86.11.8059 CrossRefPubMed

39.

Debono M, Prema A, Hughes TJ, Bull M, Ross RJ, Newell-Price J (2013) Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma. J Clin Endocrinol Metab 98(6):2383–2391. https://doi.org/10.1210/jc.2012-4276 CrossRefPubMed

40.

Yener S, Baris M, Peker A, Demir O, Ozgen B, Secil M (2017) Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up. Clin Endocrinol 87(5):425–432. https://doi.org/10.1111/cen.13408 CrossRef

41.

Bazzocchi A, Ponti F, Albisinni U, Battista G, Guglielmi G (2016) DXA: technical aspects and application. Eur J Radiol 85(8):1481–1492. https://doi.org/10.1016/j.ejrad.2016.04.004 CrossRefPubMed

42.

Kim TN, Park MS, Lee EJ, Chung HS, Yoo HJ, Kang HJ, Song W, Baik SH, Choi KM (2017) Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk. Sci Rep 7(1):6491. https://doi.org/10.1038/s41598-017-06831-7 CrossRefPubMedPubMedCentral

43.

Delivanis DA, Iniguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, Thomas MA, Gogos C, Young WF, Bancos I, Kyriazopoulou V (2018) Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol 88(2):209–216. https://doi.org/10.1111/cen.13512 CrossRef

44.

Kim JH, Kwak MK, Ahn SH, Kim H, Cho YY, Suh S, Kim BJ, Song KH, Lee SH, Koh JM (2018) Alteration in skeletal muscle mass in women with subclinical hypercortisolism. Endocrine. https://doi.org/10.1007/s12020-018-1598-0 CrossRefPubMed

45.

Dennedy MC, Annamalai AK, Prankerd-Smith O, Freeman N, Vengopal K, Graggaber J, Koulouri O, Powlson AS, Shaw A, Halsall DJ, Gurnell M (2017) Low DHEAS: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas. J Clin Endocrinol Metab 102(3):786–792. https://doi.org/10.1210/jc.2016-2718 CrossRefPubMed

46.

Papanastasiou L, Alexandraki KI, Androulakis II, Fountoulakis S, Kounadi T, Markou A, Tsiavos V, Samara C, Papaioannou TG, Piaditis G, Kaltsas G (2017) Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up. Clin Endocrinol 86(4):488–498. https://doi.org/10.1111/cen.13294 CrossRef

47.

Damjanovic SS, Antic JA, Ilic BB, Cokic BB, Ivovic M, Ognjanovic SI, Isailovic TV, Popovic BM, Bozic IB, Tatic S, Matic G, Todorovic VN, Paunovic I (2013) Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: potential role of reduced sensitivity to glucocorticoids. Mol Med 18:1456–1465. https://doi.org/10.2119/molmed.2012.00261 CrossRefPubMed

48.

Tzanela M, Mantzou E, Saltiki K, Tampourlou M, Kalogeris N, Hadjidakis D, Tsagarakis S, Alevizaki M (2012) Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas. J Endocrinol Investig 35(4):395–400. https://doi.org/10.3275/7840 CrossRef

49.

Reimondo G, Chiodini I, Puglisi S, Pia A, Morelli V, Kastelan D, Cannavo S, Berchialla P, Giachino D, Perotti P, Cuccurullo A, Paccotti P, Beck-Peccoz P, De Marchi M, Terzolo M (2016) Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas. PLoS One 11(9):e0162437. https://doi.org/10.1371/journal.pone.0162437 CrossRefPubMedPubMedCentral

50.

Xia Y, Ergun DL, Wacker WK, Wang X, Davis CE, Kaul S (2014) Relationship between dual-energy X-ray absorptiometry volumetric assessment and X-ray computed tomography-derived single-slice measurement of visceral fat. J Clin Densitom 17(1):78–83. https://doi.org/10.1016/j.jocd.2013.03.007 CrossRefPubMed

Titel: Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?
verfasst von: A. B. Moraes
E. M. R. Cavalari
M. P. de Paula
M. Arruda
D. S. C. Curi
R. A. Leitão
L. M. C. de Mendonça
M. L. F. Farias
M. Madeira
L. Vieira Neto
Publikationsdatum: 01.07.2019
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 7/2019
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-018-0985-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?